TG Therapeutics Inc (FRA:NKB2)
€ 16.336 1.19 (7.86%) Market Cap: 2.42 Bil Enterprise Value: 2.33 Bil PE Ratio: 77.18 PB Ratio: 16.39 GF Score: 72/100

TG Therapeutics Inc (FRA:NKB2) Transcripts

  • 1